174 related articles for article (PubMed ID: 11145190)
21. DOI-Induced activation of the cortex: dependence on 5-HT2A heteroceptors on thalamocortical glutamatergic neurons.
Scruggs JL; Patel S; Bubser M; Deutch AY
J Neurosci; 2000 Dec; 20(23):8846-52. PubMed ID: 11102493
[TBL] [Abstract][Full Text] [Related]
22. The involvement of the peripheral 5-HT2A receptor in peripherally administered serotonin-induced hyperglycemia in rats.
Yamada J; Sugimoto Y; Yoshikawa T; Kimura I; Horisaka K
Life Sci; 1995; 57(8):819-25. PubMed ID: 7637555
[TBL] [Abstract][Full Text] [Related]
23. Activation of 5-HT2A/2C receptors within the nucleus accumbens increases local dopaminergic transmission.
Yan QS
Brain Res Bull; 2000 Jan; 51(1):75-81. PubMed ID: 10654584
[TBL] [Abstract][Full Text] [Related]
24. The hallucinogen 1-[2,5-dimethoxy-4-iodophenyl]-2-aminopropane (DOI) increases cortical extracellular glutamate levels in rats.
Scruggs JL; Schmidt D; Deutch AY
Neurosci Lett; 2003 Aug; 346(3):137-40. PubMed ID: 12853103
[TBL] [Abstract][Full Text] [Related]
25. LSD and the phenethylamine hallucinogen DOI are potent partial agonists at 5-HT2A receptors on interneurons in rat piriform cortex.
Marek GJ; Aghajanian GK
J Pharmacol Exp Ther; 1996 Sep; 278(3):1373-82. PubMed ID: 8819525
[TBL] [Abstract][Full Text] [Related]
26. Genomic responses to 5-HT1A or 5-HT2A/2C receptor activation is differentially regulated in four regions of rat brain.
Tilakaratne N; Friedman E
Eur J Pharmacol; 1996 Jun; 307(2):211-7. PubMed ID: 8832223
[TBL] [Abstract][Full Text] [Related]
27. Evidence that 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI)-induced hyperthermia in rats is mediated by stimulation of 5-HT2A receptors.
Mazzola-Pomietto P; Aulakh CS; Wozniak KM; Hill JL; Murphy DL
Psychopharmacology (Berl); 1995 Jan; 117(2):193-9. PubMed ID: 7753967
[TBL] [Abstract][Full Text] [Related]
28. In vitro autoradiography of serotonin 5-HT(2A/2C) receptor-activated G protein: guanosine-5'-(gamma-[(35)S]thio)triphosphate binding in rat brain.
Adlersberg M; Arango V; Hsiung S; Mann JJ; Underwood MD; Liu K; Kassir SA; Ruggiero DA; Tamir H
J Neurosci Res; 2000 Sep; 61(6):674-85. PubMed ID: 10972964
[TBL] [Abstract][Full Text] [Related]
29. Discriminative stimulus effects of 1-(2,5-dimethoxy-4-methylphenyl)-2-aminopropane (DOM), ketanserin, and (R)-(+)-{alpha}-(2,3-dimethoxyphenyl)-1-[2-(4-fluorophenyl)ethyl]-4-pipidinemethanol (MDL100907) in rats.
Li JX; Unzeitig A; Javors MA; Rice KC; Koek W; France CP
J Pharmacol Exp Ther; 2009 Nov; 331(2):671-9. PubMed ID: 19687292
[TBL] [Abstract][Full Text] [Related]
30. 5-hydroxytryptamine(2A) receptors regulate sympathetic nerves constricting the cutaneous vascular bed in rabbits and rats.
Blessing WW; Seaman B
Neuroscience; 2003; 117(4):939-48. PubMed ID: 12654345
[TBL] [Abstract][Full Text] [Related]
31. Unexpected inhibitory regulation of glutamate release from rat cerebrocortical nerve terminals by presynaptic 5-hydroxytryptamine-2A receptors.
Wang SJ; Wang KY; Wang WC; Sihra TS
J Neurosci Res; 2006 Nov; 84(7):1528-42. PubMed ID: 17016851
[TBL] [Abstract][Full Text] [Related]
32. Peripherally administered serotonin induces hyperglucagonemia in mice.
Yamada J; Sugimoto Y; Kimura I; Watanabe Y; Takeuchi N; Horisaka K
Life Sci; 1993; 52(23):1845-9. PubMed ID: 8502121
[TBL] [Abstract][Full Text] [Related]
33. Discriminative stimulus effects of 1-(2,5-dimethoxy-4-methylphenyl)-2-aminopropane in rhesus monkeys: antagonism and apparent pA2 analyses.
Li JX; Rice KC; France CP
J Pharmacol Exp Ther; 2009 Mar; 328(3):976-81. PubMed ID: 19098164
[TBL] [Abstract][Full Text] [Related]
34. A pronociceptive role for the 5-HT2 receptor on spinal nociceptive transmission: an in vivo electrophysiological study in the rat.
Rahman W; Bannister K; Bee LA; Dickenson AH
Brain Res; 2011 Mar; 1382():29-36. PubMed ID: 21276431
[TBL] [Abstract][Full Text] [Related]
35. Involvement of 5-hydroxytryptamine 2A (5-HT2A) receptors in the mediation of the discriminative stimulus properties of (+/-)DOI in rats.
Chojnacka-Wójcik E; Kłodzińska A
Pol J Pharmacol; 1997; 49(5):299-304. PubMed ID: 9566028
[TBL] [Abstract][Full Text] [Related]
36. The effects of peripheral serotonin2 (5-HT2) and serotonin3 (5-HT3) receptor agonists on blood glucose levels in rats.
Sugimoto Y; Yamada J; Yoshikawa T; Horisaka K
Biol Pharm Bull; 1996 Oct; 19(10):1384-6. PubMed ID: 8913520
[TBL] [Abstract][Full Text] [Related]
37. 5-Hydroxytryptamine receptors that facilitate excitatory neuromuscular transmission in the guinea-pig isolated detrusor muscle.
Messori E; Rizzi CA; Candura SM; Lucchelli A; Balestra B; Tonini M
Br J Pharmacol; 1995 Jun; 115(4):677-83. PubMed ID: 7582490
[TBL] [Abstract][Full Text] [Related]
38. Serotonergic and dopaminergic distinctions in the behavioral pharmacology of (±)-1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI) and lysergic acid diethylamide (LSD).
Schindler EA; Dave KD; Smolock EM; Aloyo VJ; Harvey JA
Pharmacol Biochem Behav; 2012 Mar; 101(1):69-76. PubMed ID: 22197710
[TBL] [Abstract][Full Text] [Related]
39. Paradoxical effects of lithium on serotonergic receptor function: an immunocytochemical, behavioural and autoradiographic study.
Moorman JM; Leslie RA
Neuropharmacology; 1998; 37(3):357-74. PubMed ID: 9681934
[TBL] [Abstract][Full Text] [Related]
40. Agonist induced-phosphorylation of Galpha11 protein reduces coupling to 5-HT2A receptors.
Shi J; Damjanoska KJ; Singh RK; Carrasco GA; Garcia F; Grippo AJ; Landry M; Sullivan NR; Battaglia G; Muma NA
J Pharmacol Exp Ther; 2007 Oct; 323(1):248-56. PubMed ID: 17646429
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]